Santa Monica, CALIFORNIA2 Active Studies

Sjogrens Syndrome Clinical Trials in Santa Monica, CALIFORNIA

Find 2 actively recruiting sjogrens syndrome clinical trials in Santa Monica, CALIFORNIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
1,356
Enrolling

Recruiting Sjogrens Syndrome Studies in Santa Monica

About Sjogrens Syndrome Clinical Trials in Santa Monica

Sjogren's syndrome is a chronic autoimmune disorder in which the immune system attacks the glands that produce moisture, causing dry eyes and dry mouth. It can also affect joints, thyroid, kidneys, and other organs. Treatment focuses on relieving symptoms and may include immunosuppressive medications.

There are currently 2 sjogrens syndrome clinical trials recruiting participants in Santa Monica, CALIFORNIA. These studies are seeking a combined 1,356 participants. Research is being sponsored by Bristol-Myers Squibb, Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sjogrens Syndrome Clinical Trials in Santa Monica — FAQ

Are there sjogrens syndrome clinical trials in Santa Monica?

Yes, there are 2 sjogrens syndrome clinical trials currently recruiting in Santa Monica, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Monica?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Monica research site will contact you about next steps.

Are clinical trials in Santa Monica free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Monica studies also compensate for your time and travel.

What sjogrens syndrome treatments are being tested?

The 2 active trials in Santa Monica are testing new therapies including novel drugs, biologics, and treatment approaches for sjogrens syndrome.

Data updated March 2, 2026 from ClinicalTrials.gov